Refinement of Software Cost Accounting and Strengthening of the R&D Management Framework
First written in FY2018-Q2. 3 of 5 entries say "Restated". Latest entry: FY2021.
No other company in this theme has enough history to compare yet.
- FY2021AdvancedAnnual report
「We are expanding solutions and developing products to further improve the usability of our proprietary artificial intelligence engines, KIBIT and Concept Encoder, in a range of fields, including drug discovery support, diagnostic support, finance, human resources and sales support. Research and development expenses incurred by our group during the consolidated fiscal year totaled ¥154.13 million.」
The company continued developing products in multiple fields involving KIBIT and Concept Encoder, and research and development expenses increased from ¥74.594 million in the previous fiscal year to ¥154.130 million. - FY2020-Q2RestatedAnnual report
「Research and development expenses for the cumulative second-quarter period totaled ¥35.892 million.」
The company continued developing KIBIT products and solutions and disclosed research and development expenses of ¥35.892 million. - FY2018RestatedAnnual report
「As a result of this change, compared with the previous method, operating income for the current consolidated fiscal year decreased by ¥4.545 million, while ordinary loss and loss before income taxes each increased by ¥4.545 million.」
The company continued to apply the software cost accounting method changed in the second quarter and disclosed its full-year impact. - FY2018-Q3RestatedAnnual report
「As a result of this change, compared with the previous method, operating loss, ordinary loss and loss before income taxes for the nine-month period of the current consolidated fiscal year each increased by ¥3.536 million.」
The company continued to apply the software cost accounting method changed in the second quarter and disclosed its impact on the cumulative third-quarter period. - FY2018-Q2First statedAnnual report
「This change is being made to manage software costs in a timely and precise manner and to perform more appropriate software valuations and calculations of profit or loss for each period. It was prompted by the further strengthening and establishment of the organizational management system in the research and development division, which has made it possible to clearly aggregate expenses directly incurred in improving and enhancing the functions of each product.」
Beginning in the second quarter of the current consolidated fiscal year, the company changed to a cost accounting method that directly allocates expenses directly incurred in improving and enhancing software functions to the relevant products. Against the backdrop of stronger management systems in the research and development division, the company newly disclosed measures to refine cost management and the calculation of profit or loss for each period.